Genmab A/S's total assets for Q4 2025 were kr81.87B, an increase of 1066.03% from the previous quarter. DE:GE9 total liabilities were kr44.68B for the fiscal quarter, a 3418.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.